Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CYAD-211 |
Synonyms | |
Therapy Description |
CYAD-211 is a B cell maturation antigen (BCMA)-targeting chimeric antigen receptor T cell (CAR-T) therapy that coexpresses an shRNA targeting CD3z, which potentially induces killing of BCMA-expressing tumor cells (Blood 2021 138:2817, NCI Drug Dictionary). |